Advancements in omics technologies: Molecular mechanisms of acute lung injury and acute respiratory distress syndrome (Review)
- PMID: 39749711
- PMCID: PMC11722059
- DOI: 10.3892/ijmm.2024.5479
Advancements in omics technologies: Molecular mechanisms of acute lung injury and acute respiratory distress syndrome (Review)
Abstract
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is an inflammatory response arising from lung and systemic injury with diverse causes and associated with high rates of morbidity and mortality. To date, no fully effective pharmacological therapies have been established and the relevant underlying mechanisms warrant elucidation, which may be facilitated by multi‑omics technology. The present review summarizes the application of multi‑omics technology in identifying novel diagnostic markers and therapeutic strategies of ALI/ARDS as well as its pathogenesis.
Keywords: acute lung injury; acute respiratory distress syndrome; precision treatment; singe cell multi‑omics; singe cell sequence.
Conflict of interest statement
The authors declare they have no competing interests.
Figures
References
-
- Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, et al. 36th International symposium on intensive care and emergency medicine: Brussels, Belgium. 15-18 march 2016. Crit Care. 2016;20(Suppl 2):S94. doi: 10.1186/s13054-016-1208-6. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources